TR200102784T2 - Diyabet tedavisi için ilaç - Google Patents
Diyabet tedavisi için ilaçInfo
- Publication number
- TR200102784T2 TR200102784T2 TR2001/02784T TR200102784T TR200102784T2 TR 200102784 T2 TR200102784 T2 TR 200102784T2 TR 2001/02784 T TR2001/02784 T TR 2001/02784T TR 200102784 T TR200102784 T TR 200102784T TR 200102784 T2 TR200102784 T2 TR 200102784T2
- Authority
- TR
- Turkey
- Prior art keywords
- enzyme mixtures
- pancreatin
- diabetes
- digestive enzyme
- treatment
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 6
- 102000038379 digestive enzymes Human genes 0.000 abstract 4
- 108091007734 digestive enzymes Proteins 0.000 abstract 4
- 108010019160 Pancreatin Proteins 0.000 abstract 3
- 229940055695 pancreatin Drugs 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 230000003625 amylolytic effect Effects 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 230000002366 lipolytic effect Effects 0.000 abstract 2
- 230000002797 proteolythic effect Effects 0.000 abstract 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Mevcut bulus lipolitik, proteolitik ve amilolitik aktiviteye sahip, mikrobiyal ya da hayvan kaynakli fizyolojik olarak kabul edilebilir enzim karisimlarinin kullanimi, ama özellikle pankreatin ya da pankreatin ihtiva eden sindirim enzim karisimlari gibi sindirim enzim karisimlarinin diyabet tedavisi için kullanimi ile ilgilidir. Mevcut bulus ayrica bu tedaviye uygun ilaçlarin üretimi ile ilgilidir. Bulusun bir teskil tarzi sözkonusu lipolitik, proteolitik ve amilolitik aktiviteye sahip enzim karisiminin, özellikle pankreatin gibi sindirim enzim karisimlarinin veya pankreatin ihtiva eden sindirim enzim karisimlarinin Tip I ve Tip II diyabetin yardimci tedavilerinde kullanimi ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19911778 | 1999-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102784T2 true TR200102784T2 (tr) | 2002-04-22 |
Family
ID=7901217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02784T TR200102784T2 (tr) | 1999-03-17 | 2000-03-15 | Diyabet tedavisi için ilaç |
Country Status (23)
Country | Link |
---|---|
US (1) | US7122357B2 (tr) |
EP (1) | EP1162995B1 (tr) |
JP (1) | JP4938174B2 (tr) |
CN (1) | CN1221284C (tr) |
AT (1) | ATE242003T1 (tr) |
AU (1) | AU773930B2 (tr) |
BR (1) | BR0009012A (tr) |
CA (1) | CA2367355C (tr) |
CZ (1) | CZ20013345A3 (tr) |
DE (2) | DE10012095A1 (tr) |
DK (1) | DK1162995T3 (tr) |
ES (1) | ES2194720T3 (tr) |
HK (1) | HK1044477B (tr) |
HU (1) | HUP0200556A3 (tr) |
NO (1) | NO20014507D0 (tr) |
NZ (1) | NZ514826A (tr) |
PL (1) | PL199180B1 (tr) |
PT (1) | PT1162995E (tr) |
RU (1) | RU2268065C2 (tr) |
SK (1) | SK284677B6 (tr) |
TR (1) | TR200102784T2 (tr) |
WO (1) | WO2000054799A2 (tr) |
ZA (1) | ZA200107110B (tr) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7020384B1 (en) | 1999-08-12 | 2006-03-28 | Lg Electronics Inc. | Method for creating and recording transport time information for data recorded on a disk |
US6632429B1 (en) | 1999-12-17 | 2003-10-14 | Joan M. Fallon | Methods for treating pervasive development disorders |
US20070053895A1 (en) | 2000-08-14 | 2007-03-08 | Fallon Joan M | Method of treating and diagnosing parkinsons disease and related dysautonomic disorders |
US8030002B2 (en) | 2000-11-16 | 2011-10-04 | Curemark Llc | Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions |
US8100844B2 (en) * | 2002-04-25 | 2012-01-24 | Ultraflex Systems, Inc. | Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint |
US7519274B2 (en) | 2003-12-08 | 2009-04-14 | Divx, Inc. | File format for multiple track digital data |
PL1729797T3 (pl) | 2004-03-22 | 2009-02-27 | Abbott Laboratories Gmbh | Doustne kompozycje farmaceutyczne produktów zawierających lipazę, a zwłaszcza pankreatynę, zawierające środki powierzchniowo czynne |
CA2586222A1 (en) * | 2004-05-24 | 2005-12-08 | Novozymes A/S | Enzymes for pharmaceutical use |
US20060198838A1 (en) * | 2004-09-28 | 2006-09-07 | Fallon Joan M | Combination enzyme for cystic fibrosis |
BRPI0611936A2 (pt) * | 2005-06-24 | 2011-02-22 | Solvay Pharm Gmbh | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de doença |
BRPI0611932A2 (pt) * | 2005-06-24 | 2011-01-04 | Novozymes As | amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença |
US20090047266A1 (en) * | 2005-06-24 | 2009-02-19 | Novozymes A/S | Lipases for Pharmaceutical Use |
CN101233229B (zh) * | 2005-07-29 | 2013-05-01 | 雅培实验室有限公司 | 制备消毒的胰酶粉末的方法 |
PT1931317E (pt) * | 2005-08-15 | 2009-02-02 | Solvay Pharm Gmbh | Micropastilhas de pancreatina adequadas para revestimento entérico |
US11266607B2 (en) * | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) * | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
BRPI0614411A2 (pt) * | 2005-08-15 | 2011-03-29 | Solvay Pharm Gmbh | núcleos de micropéletes de pancreatina adequados para revestimento entérico |
CA2619475C (en) | 2005-08-15 | 2015-09-29 | Solvay Pharmaceuticals Gmbh | Controlled release pharmaceutical compositions for acid labile drugs |
US20080058282A1 (en) | 2005-08-30 | 2008-03-06 | Fallon Joan M | Use of lactulose in the treatment of autism |
US20070116695A1 (en) * | 2005-09-21 | 2007-05-24 | Fallon Joan M | Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders |
US8071089B2 (en) * | 2005-11-01 | 2011-12-06 | Bio-Cat, Inc. | Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
RU2009128067A (ru) | 2006-12-21 | 2011-01-27 | Новозимс А/С (Dk) | Варианты липаз для их применения в фармацевтике |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
CN101889084A (zh) | 2007-12-04 | 2010-11-17 | 诺维信公司 | 供药学应用的蛋白酶变体 |
US8658163B2 (en) | 2008-03-13 | 2014-02-25 | Curemark Llc | Compositions and use thereof for treating symptoms of preeclampsia |
US8084025B2 (en) | 2008-04-18 | 2011-12-27 | Curemark Llc | Method for the treatment of the symptoms of drug and alcohol addiction |
GB2465814B (en) * | 2008-06-19 | 2011-10-26 | Tarig Sayed Mustafa Arbab | Method,composition and device for the treatment of enzymes and saccharides disorders |
US20090324730A1 (en) * | 2008-06-26 | 2009-12-31 | Fallon Joan M | Methods and compositions for the treatment of symptoms of complex regional pain syndrome |
US9320780B2 (en) | 2008-06-26 | 2016-04-26 | Curemark Llc | Methods and compositions for the treatment of symptoms of Williams Syndrome |
PL2318035T3 (pl) | 2008-07-01 | 2019-10-31 | Curemark Llc | Sposoby i kompozycje do leczenia objawów zaburzeń neurologicznych i zaburzeń zdrowia psychicznego |
US10776453B2 (en) | 2008-08-04 | 2020-09-15 | Galenagen, Llc | Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain |
US20100092447A1 (en) | 2008-10-03 | 2010-04-15 | Fallon Joan M | Methods and compositions for the treatment of symptoms of prion diseases |
ES2727746T3 (es) | 2009-01-06 | 2019-10-18 | Galenagen Llc | Composiciones orales para el tratamiento o la prevención de infecciones por E. Coli |
JP5684725B2 (ja) | 2009-01-06 | 2015-03-18 | キュレロン リミテッド ライアビリティ カンパニー | 黄色ブドウ球菌感染の治療または予防のための組成物および方法ならびに表面上にいる黄色ブドウ球菌の根絶または低減のための組成物および方法 |
US9056050B2 (en) | 2009-04-13 | 2015-06-16 | Curemark Llc | Enzyme delivery systems and methods of preparation and use |
WO2011050135A1 (en) | 2009-10-21 | 2011-04-28 | Curemark Llc | Methods and compositions for the prevention and treatment of influenza |
CA2798280A1 (en) * | 2010-05-03 | 2011-11-10 | Aptalis Pharma Ltd. | Micropellet compositions comprising pancreatin containing digestive enzyme mixture |
WO2012145651A2 (en) | 2011-04-21 | 2012-10-26 | Curemark, Llc | Compounds for the treatment of neuropsychiatric disorders |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
US20130273026A1 (en) * | 2012-04-12 | 2013-10-17 | Integrative Enzymatics, Inc. | Composition and method for modulating inflammatory molecules with amylase |
US10350278B2 (en) | 2012-05-30 | 2019-07-16 | Curemark, Llc | Methods of treating Celiac disease |
EP3685661A4 (en) * | 2017-09-19 | 2021-05-19 | Meiji University | PROCESS FOR DEVELOPMENT OF AN ORGAN LACKING A SPECIFIC FUNCTIONAL CELL |
CN109142728A (zh) * | 2018-09-04 | 2019-01-04 | 深圳市鸿美诊断技术有限公司 | 一种定量测定粪便中胰弹性蛋白酶1的试剂盒及其应用 |
US11541009B2 (en) | 2020-09-10 | 2023-01-03 | Curemark, Llc | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803305A (en) * | 1962-12-28 | 1974-04-09 | Rolland A Lab | Process for obtaining extracts from pancreas |
DE2512746C3 (de) | 1975-03-22 | 1980-04-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin |
SU908352A1 (ru) * | 1980-02-11 | 1982-02-28 | Винницкий Областной Госпиталь Для Инвалидов Отечественной Войны | Способ лечени гнойных ран |
DE4203315A1 (de) | 1991-02-14 | 1992-08-20 | Kali Chemie Pharma Gmbh | Verfahren zur gewinnung von pankreatin |
US5614224A (en) * | 1995-04-20 | 1997-03-25 | Womack; Rick W. | Nutritional supplement for diabetics |
-
2000
- 2000-03-15 PT PT00925114T patent/PT1162995E/pt unknown
- 2000-03-15 JP JP2000604871A patent/JP4938174B2/ja not_active Expired - Lifetime
- 2000-03-15 NZ NZ514826A patent/NZ514826A/en unknown
- 2000-03-15 BR BR0009012-3A patent/BR0009012A/pt not_active Application Discontinuation
- 2000-03-15 RU RU2001126526/14A patent/RU2268065C2/ru not_active IP Right Cessation
- 2000-03-15 PL PL350627A patent/PL199180B1/pl unknown
- 2000-03-15 CN CNB008049998A patent/CN1221284C/zh not_active Expired - Lifetime
- 2000-03-15 SK SK1285-2001A patent/SK284677B6/sk unknown
- 2000-03-15 HU HU0200556A patent/HUP0200556A3/hu unknown
- 2000-03-15 EP EP00925114A patent/EP1162995B1/de not_active Expired - Lifetime
- 2000-03-15 DE DE10012095A patent/DE10012095A1/de not_active Withdrawn
- 2000-03-15 AU AU43950/00A patent/AU773930B2/en not_active Expired
- 2000-03-15 WO PCT/EP2000/002261 patent/WO2000054799A2/de active IP Right Grant
- 2000-03-15 DE DE50002450T patent/DE50002450D1/de not_active Expired - Lifetime
- 2000-03-15 CA CA2367355A patent/CA2367355C/en not_active Expired - Lifetime
- 2000-03-15 DK DK00925114T patent/DK1162995T3/da active
- 2000-03-15 CZ CZ20013345A patent/CZ20013345A3/cs unknown
- 2000-03-15 AT AT00925114T patent/ATE242003T1/de not_active IP Right Cessation
- 2000-03-15 TR TR2001/02784T patent/TR200102784T2/tr unknown
- 2000-03-15 ES ES00925114T patent/ES2194720T3/es not_active Expired - Lifetime
-
2001
- 2001-08-28 ZA ZA200107110A patent/ZA200107110B/xx unknown
- 2001-09-17 US US09/953,450 patent/US7122357B2/en not_active Expired - Lifetime
- 2001-09-17 NO NO20014507A patent/NO20014507D0/no not_active Application Discontinuation
-
2002
- 2002-08-22 HK HK02106155.6A patent/HK1044477B/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102784T2 (tr) | Diyabet tedavisi için ilaç | |
HUP0500560A2 (hu) | Mikróbás enzimek új keverékei | |
TR200101793T2 (tr) | CCR5 modülatörleri olarak azabisikloalkanlar | |
TR200200938T2 (tr) | CCR5 modülatörleri olarak piperidinler | |
BRPI0510817A (pt) | protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de uma doença | |
NO20015584L (no) | Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling | |
BR9811956B1 (pt) | naftiridinonas e composição farmacêutica compreendendo as mesmas. | |
ATE290401T1 (de) | Topisch anwendbare mittel gegen nagelpilzerkrankungen | |
BR0315688A (pt) | Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas | |
AU2526095A (en) | Transdermal device for administration through de-epithelialized skin | |
PT1019040E (pt) | Inibicao da actividade de p38-quinase por meio de arilureias | |
RU2001126526A (ru) | Лекарственное средство, предназначенное для лечения диабета | |
MXPA06001173A (es) | Metodo analitico para la pancreatina y composiciones comparables. | |
ATE214610T1 (de) | Neuartige pharmazeutische verwendungen von krill- enzymen | |
ME00578A (en) | Use of gastrointestinal lipase inhibitors | |
BR0111989A (pt) | Peptìdeos, composições e processos para o tratamento de burkholderia cepacia | |
ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
BR0014372A (pt) | Derivados de 5-hidroxissapogenina com atividade antidemência | |
ATE264340T1 (de) | Stabilisierung von gefriergetrocknetem kuchen | |
TR200101980T2 (tr) | Arilalkanoil türevleri, bunların preparasyon işlemleri | |
BR9609801A (pt) | Petídos cíclicos análogos de somatostina com atividade inibitória do desenvolvimento de hormónio | |
DE3769497D1 (de) | Mittel zur bekaempfung von phytopathogenen mikroben. | |
ATE127839T1 (de) | Varianten des gewebeplasminogenaktivators mit vermindertem abbau. | |
DE69825307D1 (de) | Verwendung von protein h als zytostattischer wirkstoff | |
DE50013908D1 (de) | Zytotoxisches t-zellepitop des papillomavirus l1-proteins und seine verwendung in diagnostik und therapie |